Filing Details
- Accession Number:
- 0001209191-17-004383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-19 13:48:47
- Reporting Period:
- 2017-01-19
- Filing Date:
- 2017-01-19
- Accepted Time:
- 2017-01-19 13:48:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533040 | Rxi Pharmaceuticals Corp | RXII | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1285648 | Geert Cauwenbergh | C/O Rxi Pharmaceuticals Corporation 257 Simarano Drive, Suite 101 Marlborough MA 01752 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2017-01-19 | 6,400 | $0.70 | 58,983 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2017-01-19 | 3,000 | $0.69 | 61,983 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2017-01-19 | 600 | $0.69 | 62,583 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.0001 Par Value | 4,500 | Indirect | By spouse |
Common Stock, $0.0001 Par Value | 450 | Indirect | By son |
Footnotes
- Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shallnot constitute an admission of beneficial ownership.